L-type Ca 2؉ channels play a critical role in regulating Ca 2؉ -dependent signaling in cardiac myocytes, including excitation-contraction coupling; however, the subcellular localization of cardiac L-type Ca 2؉ channels and their regulation are incompletely understood. Caveolae are specialized microdomains of the plasmalemma rich in signaling molecules and supported by the structural protein caveolin-3 in muscle. Here we demonstrate that a subpopulation of L-type Ca 2؉ channels is localized to caveolae in ventricular myocytes as part of a macromolecular signaling complex necessary for ␤2-adrenergic receptor (AR) regulation of ICa,L. Immunofluorescence studies of isolated ventricular myocytes using confocal microscopy detected extensive colocalization of caveolin-3 and the major pore-forming subunit of the L-type Ca channel (Ca v1.2). Immunogold electron microscopy revealed that these proteins colocalize in caveolae. Immunoprecipitation from ventricular myocytes using anti-Ca v1.2 or anti-caveolin-3 followed by Western blot analysis showed that caveolin-3, Ca v1.2, ␤2-AR (not ␤1-AR), G protein ␣s, adenylyl cyclase, protein kinase A, and protein phosphatase 2a are closely associated. To determine the functional impact of the caveolar-localized ␤2-AR͞Cav1.2 signaling complex, ␤2-AR stimulation (salbutamol plus atenolol) of ICa,L was examined in pertussis toxin-treated neonatal mouse ventricular myocytes. The stimulation of I Ca,L in response to ␤2-AR activation was eliminated by disruption of caveolae with 10 mM methyl ␤-cyclodextrin or by small interfering RNA directed against caveolin-3, whereas ␤1-AR stimulation (norepinephrine plus prazosin) of ICa,L was not altered. These findings demonstrate that subcellular localization of L-type Ca 2؉ channels to caveolar macromolecular signaling complexes is essential for regulation of the channels by specific signaling pathways.
C
ardiac voltage-gated L-type Ca 2ϩ channels play critical roles in cellular processes modulated by intracellular Ca 2ϩ such as excitation-contraction coupling and gene expression. In adult mammalian ventricular myocytes, L-type Ca 2ϩ channels have been localized to both surface and T-tubular sarcolemma (1, 2) . A significant fraction of the L-type Ca 2ϩ channels are targeted to junctional complexes composed of sarcolemmal L-type Ca 2ϩ channels in close apposition with the intracellular Ca 2ϩ release channels of the sarcoplasmic reticulum. However, there are also L-type Ca 2ϩ channels present outside of junctional complexes in cardiac muscle that may have significantly less impact on excitation-contraction coupling but could be essential for regulating other cellular functions (3, 4) . Discriminating between different subpopulations of L-type Ca 2ϩ channels in cardiac myocytes represents a critical challenge for fully understanding the role of L-type Ca 2ϩ channels in cardiac physiology and pathophysiology.
Caveolae are small invaginations of the plasma membrane enriched in cholesterol and sphingolipids, which are defined by their principal structural protein, caveolin. Caveolin-3 (Cav-3) is the specific and predominant isoform that is expressed in muscle (5) . In the heart, a variety of signaling molecules have been localized to caveolae (6) (7) (8) (9) . For example, ␤ 2 -adrenergic receptor (AR) associates with Cav-3 in neonatal mouse cardiac myocytes (10) (11) (12) . Several ion channels and exchangers have been localized to caveolae in cardiac myocytes, including the voltagedependent Na channel, a voltage-dependent K channel (K v 1.5), the Na͞Ca 2ϩ exchanger, and the HCN4 pacemaker channel (13) (14) (15) (16) . Caveolae appear to be critically involved in the regulation of Ca 2ϩ -mediated signaling in a variety of cell types (17, 18) . Nevertheless, it is not yet known whether L-type Ca 2ϩ channels are present in caveolae. The purpose of the present study was to determine whether L-type (Ca v 1.2) Ca 2ϩ channels are present in caveolae and how this localization impacts their regulation by ␤-ARs.
Results

Cav1.2 Channels and Components of the ␤-AR Signaling Cascade Are
Present in Caveolae-Enriched Membranes. To probe for the presence of Ca v 1.2 channels and signaling molecules of the ␤-AR cascade in caveolar lipid rafts in ventricular myocytes, we used a detergent-free method of membrane preparation from mouse neonatal and adult ventricular myocytes followed by continuous sucrose density gradient separation. Western blot analysis of the density gradient fractions from neonatal mouse ventricular myocytes revealed the greatest enrichment of the marker protein for caveolae, Cav-3, in the lower-density fractions 4-6 (15-20% sucrose) as shown from a typical Western blot in Fig. 1A . In the same caveolar-enriched fractions, immunoreactivity for Ca v 1.2 was detected. In contrast, the pore-forming subunit of the delayed rectifier K ϩ channel KCNH2 (hERG) was not present in the caveolar lipid raft fractions and was detected only in higher-density fractions of the gradient. Next we probed the same membrane fractions for components of the ␤-AR͞AC͞ protein kinase A (PKA) signaling cascade. An antibody to the ␤ 1 -AR detected a 65-kDa band across a broad range of the gradient fractions. The ␤ 2 -AR was more narrowly distributed, being found in the caveolin-rich fractions, similar to previous studies (19) . In addition, we detected the presence of AC, G proteins (G␣ s and G␣ i ), PKA RII , and protein phosphatase 2A (PP2A) in the caveolar-enriched fractions. Fractionation of adult mouse ventricular myocytes revealed a similar distribution of proteins across the gradient compared with neonatal myocytes (data not shown). Therefore, the major component proteins required for the ␤-AR activation of PKA as well as the Ca v 1. Fig. 2 A and B) . In the neonatal mouse myocytes, the T-tubule system is absent; however; sarcolemmal punctate areas of Ca v 1.2 (red) and Cav-3 (green) staining are observed in these cells (Fig. 2 D and E) .
Merging the red and green images ( Fig. 2 C and F Fig. 6 , which is published as supporting information on the PNAS web site). This finding suggests that Ca v 1.2 channels are present in the cells both in association with caveolae and in other membrane domains. The spatial resolution of confocal microscopy is inadequate to definitively localize proteins to caveolae given the small size of caveolae (50-100 nm). Therefore, we used the technique of immunogold labeling combined with electron microscopy on isolated neonatal mouse myocytes to determine the localization of Cav-3 and Ca v 1.2 relative to caveolae. Isolated myocytes were fixed and immunogold colabeled with anti-Cav-3 and anti-Ca v 1.2 by using a silver enhancement technique. Transmission electron micrographs revealed two distinct populations of different-sized gold particles ( Fig. 2 G and H) . The small gold particles identify anti-Cav-3 (arrowheads), and large gold particles (the result of double silver enhancement) identify anti-Ca v 1.2 (arrows). The gold particle distribution was restricted to the membrane, indicative of specific recognition of membrane-associated proteins. Furthermore, the immunogold labeling for both proteins was present on surface membrane invaginations typical of caveolae. Some Ca v 1.2 labeling was also identified outside of caveolae, demonstrating that not all Ca v 1.2 channels localize to caveolae. In control samples from which the primary antibodies had been omitted, there were rare random gold-silver particles detected (data not shown). These data dem- Complex. The L-type Ca 2ϩ channel is potently regulated by ␤-AR signaling in the heart, so we evaluated whether the caveolar Ca v 1.2 channel is associated with components of the ␤-AR͞AC͞ PKA cascade in the ventricle. Immunoprecipitation with antiCa v 1.2 was performed by using neonatal and adult mouse ventricular myocyte lysates, and Western blot analysis of eluted proteins was performed. We found that ␤ 2 -AR, G␣ s , AC, PKA RII , and PP2A coimmunoprecipitated with anti-Ca v 1.2, but ␤ 1 -AR and G␣ i did not (Fig. 3B) . Using anti-Cav-3 for immunoprecipitation, ␤ 2 -AR, G␣ S , G␣ i , AC, PKA RII , and PP2A coimmunoprecipitated, but the ␤ 1 -AR did not. We also probed immunoblots with anti-KCNH2 antibody because this protein was not present in caveolar-enriched membranes and could serve as a negative control. In agreement with this prediction, KCNH2 was detected in homogenates but did not coimmunoprecipitate with anti-Ca v 1.2 or anti-Cav-3. Comparison of the anti-Ca v 1.2 and anti-Cav-3 immunoprecipitates was remarkable for a difference in only one of the proteins probed, G␣ i , which was identified only with anti-Cav-3. These results demonstrate that the caveolar Ca v 1.2 channels are part of a macromolecular signaling complex including components of the ␤ 2 -AR͞AC͞ PKA cascade. To investigate for a functional interaction between caveolar L-type Ca 2ϩ channels and the associated ␤ 2 -ARs, we performed whole-cell electrophysiology experiments on isolated neonatal mouse ventricular myocytes. We tested the effect of ␤ 2 -AR stimulation on I Ca,L using the ␤ 2 -AR selective agonist salbutamol (Salb, 10 M) and a ␤ 1 -AR antagonist, atenolol (Aten, 10 M), to ensure ␤ 2 -AR-specific activation. In agreement with previous studies, we failed to see any effect of ␤ 2 -AR stimulation on I Ca,L in the mouse ventricular myocytes (data not shown) (20, 21) . Given the presence of G i in the caveolae and previous results showing that G i can block ␤ 2 -AR effects on I Ca,L (20) , we pretreated myocytes with pertussis toxin (PTX, 1 g͞ml) to inactivate G i . Biochemical experiments confirmed that PTX treatment resulted in G␣ i no longer immunoprecipitating with Cav-3 (Fig. 8A , which is published as supporting information on the PNAS web site). In PTX-treated myocytes, Salb plus Aten resulted in reversible stimulation of I Ca,L , shown in a representative cell in Fig. 4A , and on average I Ca,L was increased 133 Ϯ 33% (Fig. 4C) . To determine whether caveolae are essential for this regulation, we subjected PTX-treated cells first to superfusion with 10 mM M␤CD for 10 min, which disrupts caveolae by depleting cholesterol and thus disrupts the ␤ 2 -AR͞Ca v 1.2 macromolecular signaling complex (Fig. 8 B and C) . We found that M␤CD treatment completely eliminated the response to ␤ 2 -AR stimulation of I Ca,L with Salb and Aten (Fig. 4 B and C) . Subsequent application of the adrenergic agonist norepinephrine (1 M) and an ␣ 1 -adrenergic antagonist, prazosin (1 M), revealed that the ␤ 1 -AR stimulation of I Ca,L was unchanged in M␤CD-treated cells relative to untreated cells (Fig. 4) . These findings suggest that ␤ 2 -AR regulation of L-type Ca 2ϩ channels requires intact caveolae where ␤ 2 -AR and Ca v 1.2 associate. In contrast, ␤ 1 -AR regulation occurs independent of intact caveolae. (22), we investigated the impact of specific inhibition of Cav-3 expression in neonatal myocytes using siRNAmediated gene silencing. Lysates from transfected myocytes underwent immunoblotting with antibodies to Cav-3 and sarcomeric actin, a marker protein for myocytes (Fig. 5A) . The actin signal provides a control to normalize for abundance of myocytes in a preparation and thus allows calculation of a normalized Cav-3 value. The normalized Cav-3 protein level decreased by 75 Ϯ 13% (Fig. 5 A and B) . The average transfection efficiency was 64 Ϯ 7% (n ϭ 5), which suggested a nearly complete knockdown of Cav-3 protein in the transfected cells. Immunofluorescence imaging confirmed that Cav-3 siRNA-transfected cells (GFP-expressing) exhibited nearly complete knockdown of Cav-3 (Fig. 9 , which is published as supporting information on the PNAS web site).
We then performed whole-cell electrophysiology experiments on isolated PTX-treated neonatal mouse ventricular myocytes that were subjected to Cav-3 siRNA or control siRNA. Knockdown of Cav-3 did not affect average I Ca,L current densities compared with control siRNA-treated myocytes (Fig. 5C ). In myocytes that were transfected with control siRNA, Salb plus Aten resulted in an average ␤ 2 -AR stimulation of I Ca,L of 73 Ϯ 19% (Fig. 5 D and F) . In contrast, siRNA-mediated Cav-3 knockdown completely eliminated the response to ␤ 2 -AR stimulation of I Ca,L with Salb and Aten (Fig. 5 E and F) . These findings confirm that ␤ 2 -AR regulation of L-type Ca 2ϩ channels Impact of Caveolar Localization on L-Type Ca 2؉ Channel Function. The localization of ion channels to caveolae may modulate the function of the channels in multiple ways. For example, the precise lipid composition can potently regulate channel function, and dynamic changes in this composition underlie some forms of regulation. In addition, the caveolar localization of ion channels can provide compartmentalization of signaling networks, enabling rapid and specific regulation of the channels. Caveolar-localized signaling complexes composed of ␤ 2 -AR, AC, G␣ s , and G␣ i have previously been observed in rat ventricular myocytes (9, 19) , but the present study adds Ca v 1.2 and PP2A to the complex. Conversely, the molecules associated with Ca v 1.2 channels in the heart have not been extensively defined. Recent studies have identified AKAP15 and PKA as well as certain PKC isoforms in association with Ca v 1.2 in cardiac muscle (23, 24) ; however, whether these molecules are associated with the channels in caveolae is unknown. The present results add to the list of proteins known to be associated with Ca v 1.2 in the heart, including ␤ 2 -AR, G␣ s , AC, and PP2A. Studies in rat brain have identified a similar macromolecular signaling complex including ␤ 2 -AR and Ca v 1.2 (25) . In neurons, Ca v 1.2 is clustered with glutamate receptors in dendritic spines, which are devoid of morphological caveolae and constitute the postsynaptic sites of glutaminergic synapses. However, the postsynaptic site, and especially the postsynaptic density, constitutes a special subcompartment of the plasma membrane, which may resemble in several respects caveolae, including a dense protein scaffold network on the inside and the requirement of cholesterol for its integrity (26) . Therefore, localization of ␤ 2 -AR͞Ca v 1.2 signaling complexes in various tissues may share certain preferred lipid environments, although the details of the associated scaffolding proteins and other signaling molecules may vary substantially. The functional impact of the colocalization of Ca v 1.2 and ␤ 2 -AR has been observed in previous studies in both cardiac myocytes and neurons, which have demonstrated highly localized regulation of L-type Ca 2ϩ channels by ␤ 2 -AR stimulation (25, (27) (28) (29) . In addition, single-channel studies using rat ventricular myocytes comparing the effects of ␤ 1 -AR and ␤ 2 -AR activation have identified differential patterns of stimulation of single L-type Ca 2ϩ channel activity, which is consistent with distinct localization and regulation of channels by ␤ 1 -AR and ␤ 2 -ARs (30) . The present work demonstrates that the underlying basis for the localized regulation of I Ca,L in the heart is the colocalization of the ␤ 2 -AR͞AC͞PKA signaling molecules in caveolae along with L-type Ca 2ϩ channels.
Caveolae-Localized L-Type Ca 2؉ Channels and Integrated Caveolar Ca 2؉ Signaling. This study adds the L-type Ca 2ϩ channel to a growing collection of proteins involved in cellular Ca 2ϩ cycling that have been localized to caveolae. The IP 3 receptor, Na ϩ ͞ Ca 2ϩ exchanger, plasma membrane Ca 2ϩ -ATPase, and members of the transient receptor potential family have been localized to caveolae in various cell types (17, 18, 31, 32) . Previous studies of cardiomyocytes have suggested that the Na ϩ ͞Ca 2ϩ exchanger protein and the plasma membrane Ca 2ϩ -ATPase are present in caveolae (15, 33) . Therefore, the caveolar submembrane domain employs multiple proteins to regulate Ca 2ϩ levels, which in turn regulate a variety of caveolar proteins such as Ca 2ϩ -sensitive isoforms of adenylyl cyclase (AC5, AC6, and AC8) and endothelial NO synthase (9, 10, 34, 35) .
The role of caveolar L-type Ca 2ϩ channels in excitationcontraction coupling in the heart is not well defined. One previous study demonstrated that disruption of caveolae in neonatal rat ventricular myocytes with M␤CD reduced the frequency, amplitude, and width of Ca 2ϩ sparks (36) . The authors suggested that Ca 2ϩ sparks form specifically in caveolar microdomains. However, the ultrastructure of adult cardiomyocytes is different, with the formation of the T-tubule system and highly structured junctional domains. The junctional domains between sarcolemma-containing L-type Ca 2ϩ channels and junctional sarcoplasmic reticulum likely provide the major site for excitation-contraction coupling and Ca 2ϩ spark generation, and thus the caveolar Ca 2ϩ channels may be more peripherally involved in excitation-contraction coupling in adult myocytes. Even without providing the triggering Ca 2ϩ for sarcoplasmic reticulum release, they may provide an important source for sarcoplasmic reticulum Ca 2ϩ loading.
Conclusions and Limitations
These findings demonstrate that a subpopulation of L-type Ca 2ϩ channels in mouse ventricular myocytes are localized to caveolae, where they are part of a macromolecular signaling complex necessary for ␤ 2 -AR, but not ␤ 1 -AR, regulation of Ca v 1.2 channels. Many questions remain to understand the functional role and molecular identity of the caveolar-localized Ca 2ϩ channels. What mechanisms target the channels to caveolae? What is the molecular composition of the caveolar channels regarding auxiliary subunit composition as well as alternatively spliced forms of Ca v 1.2? Do alterations in caveolae and caveolar signaling processes play a role in pathophysiology of the heart such as cardiac hypertrophy and heart failure? Our studies provide the basis to address these critical questions in the future.
Materials and Methods
Isolation of Ventricular Myocytes and Purification of Caveolae-Rich
Fractions. Neonatal or adult mouse as well as adult canine ventricular myocytes were enzymatically isolated as previously described (37, 38) . Caveolin-rich fractions from neonatal mouse ventricular myocytes were prepared by using a previously described detergent-free method (39) with some modifications (see Supporting Methods, which is published as supporting information on the PNAS web site). From each gradient, 1-ml gradient fractions were collected to yield a total of 12 fractions.
Immunoblotting. Gradient fractions were analyzed by SDS͞ PAGE and Western blot analysis (see Supporting Methods). Immunoblots were probed with antibodies to Ca v 1.2 (rabbit polyclonal) (40), Cav-3, PKA RII␣ , PP2A, and G␣ i (mouse monoclonal antibodies; BD Transduction Laboratories), AC V͞VI, ␤ 1 -AR, ␤ 2 -AR (rabbit polyclonal antibodies; Santa Cruz Biotechnology), G␣ s (rabbit polyclonal; Chemicon International, Temecula, CA), and anti-KCNH2 (rabbit polyclonal) (41).
Immunofluorescence. Immunolabeling was performed on isolated mouse neonatal and adult canine ventricular myocytes by using a rabbit polyclonal anti-Ca v 1.2 subunit and monoclonal antiCav-3 antibodies as described elsewhere (1). Cells were ran-domly selected and used for imaging and analysis, and immunolabeling experiments were repeated at least five times.
Electron Microscopy. Immunogold labeling and colocalization of Cav-3 and Ca v 1.2 were performed on isolated neonatal mouse myocytes by using a silver enhancement method (42) (for details see Supporting Methods).
Immunoprecipitation. For immunoprecipitations, adult or neonatal mouse myocyte lysates (Ϸ2 mg of protein) were used, and immunoprecipitations were carried out by using anti-Cav-3 (5 g) or anti-Ca v 1.2 (10 g) antibodies, or control Igs were used at the same concentrations as the specific antibodies (see Supporting Methods). Immune complexes were analyzed by SDS͞ PAGE and Western blot by probing with antibodies to Ca v 1.2, Cav-3, PKA RII␣ , PP2A, AC V͞VI, ␤ 1 -AR, ␤ 2 -AR, G␣ s , G␣ i , and KCNH2.
siRNA-Mediated Cav-3 Knockdown. Three predesigned Cav-3-specific siRNA sequences (Ambion Silencer Predesigned siRNA, HPLC-purified, annealed, catalog nos. 160017, 160018, and 160019 for mouse Cav-3, GenBank accession no. NM007617) and control nonspecific siRNA oligos for mouse (Ambion, Silencer Negative Control #1 siRNA) were used for Cav-3 knockdown as described in Supporting Methods.
Electrophysiology. Whole-cell perforated patch clamp was performed on isolated mouse neonatal cardiomyocytes as described in Supporting Methods. 
